[go: up one dir, main page]

GB0625826D0 - New compounds - Google Patents

New compounds

Info

Publication number
GB0625826D0
GB0625826D0 GB0625826A GB0625826A GB0625826D0 GB 0625826 D0 GB0625826 D0 GB 0625826D0 GB 0625826 A GB0625826 A GB 0625826A GB 0625826 A GB0625826 A GB 0625826A GB 0625826 D0 GB0625826 D0 GB 0625826D0
Authority
GB
United Kingdom
Prior art keywords
new compounds
compounds
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0625826A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astex Therapeutics Ltd
Original Assignee
Astex Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astex Therapeutics Ltd filed Critical Astex Therapeutics Ltd
Priority to GB0625826A priority Critical patent/GB0625826D0/en
Publication of GB0625826D0 publication Critical patent/GB0625826D0/en
Priority to TW96148021A priority patent/TWI415609B/en
Priority to DK07848659.4T priority patent/DK2114941T5/en
Priority to RU2009128188/04A priority patent/RU2466130C2/en
Priority to JP2009542223A priority patent/JP5442448B2/en
Priority to SI200731661T priority patent/SI2114941T1/en
Priority to EP07848659.4A priority patent/EP2114941B1/en
Priority to HRP20150642TT priority patent/HRP20150642T1/en
Priority to PCT/GB2007/004934 priority patent/WO2008078091A1/en
Priority to MX2009006706A priority patent/MX2009006706A/en
Priority to CN200780047672.6A priority patent/CN101679408B/en
Priority to BRPI0720352-7A2A priority patent/BRPI0720352A2/en
Priority to ES07848659.4T priority patent/ES2541658T3/en
Priority to US12/520,481 priority patent/US8895745B2/en
Priority to CA2672172A priority patent/CA2672172C/en
Priority to HUE07848659A priority patent/HUE026521T2/en
Priority to ARP070105856A priority patent/AR064491A1/en
Priority to AU2007337886A priority patent/AU2007337886C1/en
Priority to NO20092657A priority patent/NO343370B1/en
Ceased legal-status Critical Current

Links

GB0625826A 2006-12-22 2006-12-22 New compounds Ceased GB0625826D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GB0625826A GB0625826D0 (en) 2006-12-22 2006-12-22 New compounds
TW96148021A TWI415609B (en) 2006-12-22 2007-12-14 New compounds
AU2007337886A AU2007337886C1 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as FGFR inhibitors
PCT/GB2007/004934 WO2008078091A1 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as fgfr inhibitors
BRPI0720352-7A2A BRPI0720352A2 (en) 2006-12-22 2007-12-21 COMPOUND, PROCESS FOR PREPARING A COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF A COMPOUND, AND METHODS FOR PROPHYLAXY OR TREATMENT OF A STATE OR DISEASE AND CANCER.
JP2009542223A JP5442448B2 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as FGFR inhibitors
SI200731661T SI2114941T1 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as fgfr inhibitors
EP07848659.4A EP2114941B1 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as fgfr inhibitors
HRP20150642TT HRP20150642T1 (en) 2006-12-22 2007-12-21 BIKE HETEROCYCLIC SUBSTANCES AS FGFR INHIBITORS
DK07848659.4T DK2114941T5 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as FGFR inhibitors
MX2009006706A MX2009006706A (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as fgfr inhibitors.
CN200780047672.6A CN101679408B (en) 2006-12-22 2007-12-21 Bicyclic heterocycles as FGFR inhibitors
RU2009128188/04A RU2466130C2 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as fgfr inhibitors
ES07848659.4T ES2541658T3 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as inhibitors of FGFR
US12/520,481 US8895745B2 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as FGFR inhibitors
CA2672172A CA2672172C (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as fgfr inhibitors
HUE07848659A HUE026521T2 (en) 2006-12-22 2007-12-21 Bicyclic heterocyclic compounds as fgfr inhibitors
ARP070105856A AR064491A1 (en) 2006-12-22 2007-12-21 IMIDAZO DERIVATIVES [1, 2-A] PYRIMIDINE, A PROCESS FOR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN THE TREATMENT OF DISEASES MEDIATED BY FGFR KINASES.
NO20092657A NO343370B1 (en) 2006-12-22 2009-07-13 Bicyclic heterocyclic compounds such as FGFR inhibitors, pharmaceutical composition and therapeutic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0625826A GB0625826D0 (en) 2006-12-22 2006-12-22 New compounds

Publications (1)

Publication Number Publication Date
GB0625826D0 true GB0625826D0 (en) 2007-02-07

Family

ID=37758985

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0625826A Ceased GB0625826D0 (en) 2006-12-22 2006-12-22 New compounds

Country Status (2)

Country Link
GB (1) GB0625826D0 (en)
RU (1) RU2466130C2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0810902D0 (en) * 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
IL312674A (en) 2018-01-29 2024-07-01 Merck Patent Gmbh Gcn2 inhibitors and uses thereof
RU2678455C1 (en) * 2018-06-01 2019-01-29 Сергей Викторович Леонов N-(3-(5-(4-chlorophenyl)-1n-pyrazolo[3,4-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulphonamide crystalline form, active component, pharmaceutical composition and medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990146A (en) * 1997-08-20 1999-11-23 Warner-Lambert Company Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation
GB9919778D0 (en) * 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
ATE402164T1 (en) * 2001-04-26 2008-08-15 Eisai R&D Man Co Ltd NITROGEN CONTAINING COMPOUND HAVING A CONDENSED RING AND PYRAZOLYL GROUP AS A SUBSTITUENT AND MEDICAL COMPOSITION THEREOF
AU2005278292B2 (en) * 2004-08-31 2011-09-08 Msd K.K. Novel substituted imidazole derivatives

Also Published As

Publication number Publication date
RU2009128188A (en) 2011-01-27
RU2466130C2 (en) 2012-11-10

Similar Documents

Publication Publication Date Title
IL226046A0 (en) New compounds
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
EP1984379A4 (en) Anti-arenaviral compounds
GB0605786D0 (en) Compounds
GB0606876D0 (en) Compounds
GB0619325D0 (en) New compounds
GB0605784D0 (en) Compounds
GB0605785D0 (en) Compounds
EP2004174A4 (en) Naphthalenedione compounds
GB0606913D0 (en) Compounds
GB0602042D0 (en) Compounds
GB0625826D0 (en) New compounds
EP1973905A4 (en) Compounds
GB0625827D0 (en) New compounds
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
HU0600920D0 (en) New compounds
HU0600919D0 (en) New compounds
HU0600918D0 (en) New compounds
HU0600726D0 (en) New compounds
GB0611836D0 (en) New compounds
GB0602856D0 (en) Compounds
GB0602853D0 (en) Compounds
GB0602455D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)